4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

休市中 04-04 16:00:00 EDT

2.77

-0.11

-3.99%

盘后2.77

+0.000.00%

19:16 EDT

最高2.85	最低2.67	成交量61.22万
今开2.82	昨收2.89	日振幅6.33%
总市值1.28亿	流通市值9,504万	总股本4,630万
成交额167.94万	换手率1.78%	流通股本3,431万
市净率0.25	ROE-39.31%	每股收益-2.98
52周最高29.27	52周最低2.67	市盈率-0.93
股息0.00	股息收益率0.00	ROA-26.08%

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":2.77,"timestamp":1743796800000,"preClose":2.885,"halted":0,"volume":612164,"hourTrading":{"tag":"盘后","latestPrice":2.77,"preClose":2.77,"latestTime":"19:16 EDT","volume":64950,"amount":179911.52,"timestamp":1743808573502},"delay":0,"floatShares":34309254,"shares":46302407,"eps":-2.982143,"marketStatus":"休市中","change":-0.115,"latestTime":"04-04 16:00:00 EDT","open":2.82,"high":2.8527,"low":2.67,"amount":1679443.0398592001,"amplitude":0.063328,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.982143,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":2.885,"preHourTrading":{"tag":"盘前","latestPrice":2.75,"preClose":2.885,"latestTime":"09:27 EDT","volume":135,"amount":388.920015,"timestamp":1743773274271},"postHourTrading":{"tag":"盘后","latestPrice":2.77,"preClose":2.77,"latestTime":"19:16 EDT","volume":64950,"amount":179911.52,"timestamp":1743808573502},"volumeRatio":0.6040888673112498,"impliedVol":1.7883,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/FDMT","defaultTab":"news","newsList":[{"id":"2518203767","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518203767?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:38","pubTimestamp":1741628301,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时38分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5248.29%、3822.86%、989.14%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311013822abf35662&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311013822abf35662&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2518039742","title":"B of A Securities：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由42.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518039742","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518039742?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626170,"startTime":"0","endTime":"0","summary":"B of A Securities：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由42.00美元调整至40.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11010248641319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FDMT","LENZ"],"gpt_icon":0},{"id":"2516677872","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677872?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:38","pubTimestamp":1741099111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时38分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.31%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1098.02%、1092.28%、428.16%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.，振幅分别为37.67%、22.25%、19.21%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223831abe7f210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223831abe7f210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2516634461","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.41%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634461?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:36","pubTimestamp":1741012585,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时36分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.41%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.35%、32.71%、30.88%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、16.68%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223626989a10bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223626989a10bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2516302389","title":"4D Molecular Therapeutics(FDMT.US)：2024年Q4财报实现营收1000美元，前值为-17000美元，预期值为220万美元；每股收益为-0.90美元，前值为-0.77美元，预期值为-0.83美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516302389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516302389?lang=zh_cn&edition=full","pubTime":"2025-03-01 05:36","pubTimestamp":1740778585,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics(FDMT.US)：2024年Q4财报实现营收1000美元，前值为-17000美元，预期值为220万美元；每股收益为-0.90美元，前值为-0.77美元，预期值为-0.83美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01053648470340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"1150248678","title":"4D 分子治疗公司2024财年GAAP每股收益$(2.98)不及预期$(2.92)，销售额为$37.000K","url":"https://stock-news.laohu8.com/highlight/detail?id=1150248678","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150248678?lang=zh_cn&edition=full","pubTime":"2025-03-01 05:14","pubTimestamp":1740777276,"startTime":"0","endTime":"0","summary":"4D 分子治疗公司(FDMT)2024财年GAAP每股收益$(2.98)不及预期$(2.92)，销售额为$37.000K。以上内容来自Benzinga Earnings专栏，原文如下：$4D Molecular Therapeutics(FDMT)$ FY 2024 GAAP EPS $(2.98) Misses $(2.92) Estimate, Sales $37.000K","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"4D 分子治疗公司2024财年GAAP每股收益$(2.98)不及预期$(2.92)，销售额为$37.000K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT"],"gpt_icon":0},{"id":"2514320275","title":"4D Molecular Therapeutics, Inc.盘中异动 大幅下跌6.25%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320275?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:42","pubTimestamp":1740753752,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时42分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速跳水6.25%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为505.08%、312.74%、260.36%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Anaptysbio, Inc.，振幅分别为31.14%、29.25%、21.59%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822423298967cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822423298967cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2514331727","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘大幅下跌5.00%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331727?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:32","pubTimestamp":1740684725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时32分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报4.56美元/股，成交量22.6878万股，换手率0.49%，振幅6.15%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228033205a256bd72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228033205a256bd72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2514579258","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.07%报4.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514579258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514579258?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:06","pubTimestamp":1740585971,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时06分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速拉升5.07%。截至发稿，该股报4.77美元/股，成交量9.8658万股，换手率0.21%，振幅5.51%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006119893bcd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006119893bcd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2511491696","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511491696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511491696?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:33","pubTimestamp":1739543608,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.24%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1054.33%、372.17%、339.53%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.、Theratechnologies Inc.，振幅分别为20.20%、19.73%、18.33%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422332896231bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422332896231bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2510380813","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.17%报5.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380813?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284581,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下跌5.17%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2091.99%、549.12%、189.61%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为25.06%、22.23%、20.37%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223622a241fc2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223622a241fc2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2510665808","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510665808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510665808?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739198007,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速跳水5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.、Solid Biosciences Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为909.72%、598.06%、255.77%，振幅较大的相关个股有Tyra Biosciences, Inc.、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为100.83%、26.71%、22.45%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223328abc9a5a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223328abc9a5a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2509767227","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509767227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509767227?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:43","pubTimestamp":1738960981,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时43分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下跌5.21%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Sionna Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为9166.29%、185.34%、168.41%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为130.43%、93.55%、66.67%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208044301abc678ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208044301abc678ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2509561258","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘快速上涨5.05%报6.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509561258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509561258?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:13","pubTimestamp":1738782835,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时13分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速拉升5.05%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.20%。其相关个股中，Transcode Therapeutics, Inc.、Invivyd, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4622.03%、2340.77%、1745.36%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、67.19%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206031356abc3b7ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206031356abc3b7ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2508576774","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.06%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508576774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508576774?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:36","pubTimestamp":1738679787,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时36分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅下跌5.06%。截至发稿，该股报5.63美元/股，成交量3.3319万股，换手率0.07%，振幅3.71%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042236279617d85d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042236279617d85d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2508867127","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.00%报5.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508867127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508867127?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:02","pubTimestamp":1738612932,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时02分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速拉升5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Invivyd, Inc.、Hcw Biologics Inc.、Gh Research Plc涨幅较大，Cyclerion Therapeutics, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为1004.89%、740.65%、473.59%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、151.80%、63.94%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204040213abc149d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204040213abc149d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2507496980","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.00%报5.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507496980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507496980?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:51","pubTimestamp":1738335119,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时51分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速下挫5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1646.05%、891.80%、90.60%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为63.20%、48.82%、42.27%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131225200987761c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131225200987761c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2507581673","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507581673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507581673?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:24","pubTimestamp":1738254274,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时24分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1636.71%、230.99%、210.46%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为65.98%、61.86%、56.41%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131002434a23468c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131002434a23468c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2506308008","title":"4D Molecular Therapeutics, Inc.盘中异动 急速拉升5.15%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506308008?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:43","pubTimestamp":1737988987,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时43分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速上涨5.15%。截至发稿，该股报4.90美元/股，成交量2.4213万股，换手率0.05%，振幅5.69%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272243079874b16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272243079874b16c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2505608026","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.21%报4.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505608026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505608026?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:28","pubTimestamp":1737664085,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时28分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速拉升5.21%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7428.23%、7375.58%、1156.33%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为948.57%、261.32%、172.73%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042805abb63f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042805abb63f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.2369},{"period":"1month","weight":-0.3341},{"period":"3month","weight":-0.5329},{"period":"6month","weight":-0.7222},{"period":"1year","weight":-0.8998},{"period":"ytd","weight":-0.5027}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家领先的临床阶段生物制药公司，专注于通过针对特定疾病治疗进行优化的专有定制载体释放基因药物的全部潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.090662},{"month":2,"riseRate":0.2,"avgChangeRate":0.041082},{"month":3,"riseRate":0.6,"avgChangeRate":-0.023896},{"month":4,"riseRate":0.2,"avgChangeRate":-0.13276},{"month":5,"riseRate":0.5,"avgChangeRate":-0.163827},{"month":6,"riseRate":0,"avgChangeRate":-0.078465},{"month":7,"riseRate":0.75,"avgChangeRate":0.059232},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049809},{"month":9,"riseRate":0.25,"avgChangeRate":-0.148039},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11181},{"month":11,"riseRate":0.5,"avgChangeRate":0.477816},{"month":12,"riseRate":0.25,"avgChangeRate":0.044012}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}